Article
Fibroblast growth factor receptors-1 and -3 play distinct roles in the regulation of bladder cancer growth and metastasis: implications for therapeutic targeting.
PloS one - 1 Jan 2013
Cheng Tiewei, Roth Beat, Choi Woonyoung, Black Peter C, Dinney Colin, McConkey David J
Abstract excerpt
Fibroblast growth factor receptors (FGFRs) are activated by mutation and overexpressed in bladder cancers (BCs), and FGFR inhibitors are currently being evaluated in clinical trials in BC patients. However, BC cells display marked heterogeneity in their responses to FGFR inhibitors, and the biological mechanisms underlying this heterogeneity are not well defined. Here we used a novel inhibitor of FGFRs 1-3 and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
